East Resources Acquisition Co

An authorization is a ceiling and an expiry date, not a purchase: up to $100 million may be bought at the company's discretion through May 6, 2028, and the filing reports no shares repurchased.

Revenue grew 30% while net income fell 62%, because operating expenses grew faster than revenue — G&A alone rose $14.0 million. The company bought back roughly 2.7 million shares for about $24.4 million during the half-year while its life settlement portfolio at fair value shrank $85.8 million.

GAAP net income fell 63% while every adjusted measure rose, and the gap is acquisition and personnel cost the adjusted figures exclude. Cash of $23.4 million sits against $330.6 million of debt and $383.0 million of policy assets carried at fair value — the balance sheet is the inventory, and its value is an estimate rather than a market price.

A $75 million incremental term loan drawn under an accordion feature is growth capital raised without issuing equity, which for former ERES holders means the expansion is funded without diluting them. The trade-off is leverage: the incremental loans rank alongside the existing secured facility and ahead of the common stock, and the collateral agent's involvement confirms the debt is secured on the company's assets. Whether that is prudent depends on the return the incremental capital earns against its interest cost.

This is a warrant retirement, not a business combination: the company is buying in its own warrant overhang by issuing 0.23 of a share per warrant. The exchange ratio is fixed and the deadline is hard — 11:59 p.m. ET on July 29, 2025 — with withdrawal rights ending at the same moment, so a holder who does nothing keeps a warrant rather than receiving shares. The paired consent solicitation is the mechanism by which the warrant agreement can be amended to reach warrants that are not tendered, so the outcome for non-tendering holders depends on whether the consent threshold is met.

This version supplies the arithmetic the amendment does not: 20,623,395 warrants outstanding in total against a maximum issuance of 4,743,381 shares, which is exactly the 0.23 ratio applied to every warrant. That figure is the upper bound on the dilution from the exchange, and it is the price of removing the entire warrant overhang. Because fractional shares are not issued, a holder tendering a small odd number of warrants loses the fractional remainder. The deadline of 11:59 p.m. ET on July 29, 2025 governs both tendering and withdrawal.

What changed: The filing is an 8-K under Item 7.01 (Regulation FD Disclosure) filed by Abacus Global Management, Inc., attaching a shareholder letter and press release dated August 24, 2026, regarding a 'valuation update and mid-year outlook.' The document contains no information regarding ERES redemption deadlines, trust value, extensions, or deal progress because the SPAC status is CLOSED. The filing does not report any resignations, lawsuits, or specific financial figures; it merely furnishes the attached communication as non-filed information for regulatory purposes. Why it matters: This filing confirms that Abacus Global Management, Inc. distributed a valuation update to shareholders on August 24, 2026, but provides no actionable data for investors tracking ERES specifically, as the entity is closed. For investors monitoring Abacus Global Management, Inc., this serves as a notice of their mid-year outlook communication, though the SEC disclaimer explicitly states the information is furnished, not filed, and carries no liability under Section 18 of the Securities Exchange Act of 1934.

What changed: Items 7.01 and 8.01 8-K of Abacus Global Management, Inc. (NYSE: ABX). On August 13, 2026 the Board authorized a new stock repurchase program commencing August 17, authorizing the purchase of up to $100 million of the company's common stock in the open market or in privately negotiated transactions, including accelerated share repurchases, block trades and Rule 10b5-1 plans, from time to time until May 6, 2028. A press release announcing the program is furnished as Exhibit 99.1. Why it matters: An authorization is a ceiling and an expiry date, not a purchase: up to $100 million may be bought at the company's discretion through May 6, 2028, and the filing reports no shares repurchased.